Evidence map›Paper›PMID 18926873›Full record

ReviewProgress in neurobiology2009

Nanotechnology, nanotoxicology, and neuroscience.

Won Hyuk Suh, Kenneth S Suslick, Galen D Stucky, Yoo-Hun Suh

Open access · greenAbstract readReview
In one paragraph

Review in Progress in neurobiology, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 68 papers.

0numbers the graph read from it
0cells of the map it votes in
68citing papers in PubMed
12.0field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

68 citing papers in PubMed, 396 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Review
  5. Article
  6. Article
  7. Review
  8. Article
  9. Review
  10. Article
  11. Article
  12. Review
  13. Article
  14. Review
  15. Review
  16. Review
  17. Nanotoxicity: a challenge for future medicineTurkish journal of medical sciences · 2020
    Review
  18. Article
  19. Biomedical Applications of TiOInternational journal of nanomedicine · 2020
    Review
  20. Safety Assessment of Nanomaterials to Eyes: An Important but Neglected Issue.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2019
    Review

8 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 3 institutions in 2 countries.

Won Hyuk SuhDepartment of Chemistry and Biochemistry, Materials Department, University of California, Santa Barbara, CA 93106, USA.
Kenneth S Suslick
Galen D Stucky
Yoo-Hun Suh
University of California, Santa Barbara · USSeoul National University · KRUniversity of Illinois Urbana-Champaign · US

Funding

A VOC Dosimeter Based On A Colorimetric Sensor ArrayU01ES016011 · NIEHS · UNIVERSITY OF ILLINOIS AT URBANA-CHAMPAIGN · PI SUSLICK, KENNETH S · 2007 to 2010
$2.7M
SYNTHETIC ANALOGUES OF HEME PROTEINSR01HL025934 · NHLBI · UNIVERSITY OF ILLINOIS URBANA-CHAMPAIGN · PI SUSLICK, KENNETH S · 1985 to 2004
$1.6M
NHLBI NIH HHS HL 25934NHLBI NIH HHS R01 HL025934NIEHS NIH HHS U01 ES016011
6 · The paper itself

Abstract

Nanotechnology, which deals with features as small as a 1 billionth of a meter, began to enter into mainstream physical sciences and engineering some 20 years ago. Recent applications of nanoscience include the use of nanoscale materials in electronics, catalysis, and biomedical research. Among these applications, strong interest has been shown to biological processes such as blood coagulation control and multimodal bioimaging, which has brought about a new and exciting research field called nanobiotechnology. Biotechnology, which itself also dates back approximately 30 years, involves the manipulation of macroscopic biological systems such as cells and mice in order to understand why and how molecular level mechanisms affect specific biological functions, e.g., the role of APP (amyloid precursor protein) in Alzheimer's disease (AD). This review aims (1) to introduce key concepts and materials from nanotechnology to a non-physical sciences community; (2) to introduce several state-of-the-art examples of current nanotechnology that were either constructed for use in biological systems or that can, in time, be utilized for biomedical research; (3) to provide recent excerpts in nanotoxicology and multifunctional nanoparticle systems (MFNPSs); and (4) to propose areas in neuroscience that may benefit from research at the interface of neurobiologically important systems and nanostructured materials.

Indexed as

NeurosciencesAnimalsDrug Delivery SystemsHumansNanostructuresNanotechnologyToxicology

Identifiers

PMID18926873
PMCPMC2728462
OpenAlexW2094624111

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.